Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelly McNeil

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
Vaccine|October 4, 2005
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsScott A Halperin, Simon Dobson, Shelly McNeil, et al.
Plos Medicine|May 11, 2010
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receiptGina Ogilvie, Maureen Anderson, Fawziah Marra, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
Infection Control and Hospital Epidemiology|June 19, 2019
Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010-2011 to 2013-2014Lili Jiang, Allison McGeer, Shelly McNeil, et al.
Antiviral Research|February 10, 2017
Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, CanadaBrenda L Coleman, Kazi Hassan, Karen Green, et al.
Idcases|October 17, 2025
Pathological investigation and microbiological confirmation of <i>Bartonella quintana</i> endocarditis: A case of trench fever without the trench or feverNardeen Grace, Jason J LeBlanc, Carl Boodman, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 7, 2024
Assessing a safety climate tool adapted to address respiratory illnesses in Canadian hospitalsLili Jiang, Matthew Muller, Allison McGeer, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
Vaccine|October 4, 2005
Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsScott A Halperin, Simon Dobson, Shelly McNeil, et al.
Plos Medicine|May 11, 2010
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receiptGina Ogilvie, Maureen Anderson, Fawziah Marra, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
Infection Control and Hospital Epidemiology|June 19, 2019
Which healthcare workers work with acute respiratory illness? Evidence from Canadian acute-care hospitals during 4 influenza seasons: 2010-2011 to 2013-2014Lili Jiang, Allison McGeer, Shelly McNeil, et al.
Antiviral Research|February 10, 2017
Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, CanadaBrenda L Coleman, Kazi Hassan, Karen Green, et al.
Idcases|October 17, 2025
Pathological investigation and microbiological confirmation of <i>Bartonella quintana</i> endocarditis: A case of trench fever without the trench or feverNardeen Grace, Jason J LeBlanc, Carl Boodman, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|October 7, 2024
Assessing a safety climate tool adapted to address respiratory illnesses in Canadian hospitalsLili Jiang, Matthew Muller, Allison McGeer, et al.
BMC Public Health|June 3, 2014
Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigationAmy Schneeberg, Julie A Bettinger, Shelly McNeil, et al.
Pageof 7